These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Cardioprotection by estrogens: mechanisms of action--the lipids. Samsioe G Int J Fertil Menopausal Stud; 1994; 39 Suppl 1():43-9. PubMed ID: 8199640 [TBL] [Abstract][Full Text] [Related]
29. Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. N Engl J Med; 1974 Jan; 290(1):15-9. PubMed ID: 4357161 [TBL] [Abstract][Full Text] [Related]
30. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
31. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer. Vassilopoulou-Sellin R; Theriault RL J Natl Cancer Inst Monogr; 1994; (16):153-9. PubMed ID: 7999459 [TBL] [Abstract][Full Text] [Related]
32. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus. Petersen KR Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723 [TBL] [Abstract][Full Text] [Related]
33. The effects of estradiol on blood lipids and lipoproteins in postmenopausal women. Fåhraeus L Obstet Gynecol; 1988 Nov; 72(5 Suppl):18S-22S. PubMed ID: 3173937 [TBL] [Abstract][Full Text] [Related]
34. Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapy. Falcó C; Tormo G; Estellés A; España F; Tormo E; Gilabert J; Velasco JA; Aznar J Haematologica; 2001 Jan; 86(1):92-8. PubMed ID: 11146577 [TBL] [Abstract][Full Text] [Related]
35. Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: a randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens. Mijatovic V; van der Mooren MJ; Kenemans P; de Valk-de Roo GW; Netelenbos C Menopause; 1999; 6(2):134-7. PubMed ID: 10374220 [TBL] [Abstract][Full Text] [Related]
36. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium. Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899 [TBL] [Abstract][Full Text] [Related]
37. The effects of postmenopausal estrogen therapy on the incidence of arteriosclerotic vascular disease. Knopp RH Obstet Gynecol; 1988 Nov; 72(5 Suppl):23S-30S. PubMed ID: 3050656 [TBL] [Abstract][Full Text] [Related]
39. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study. Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192 [TBL] [Abstract][Full Text] [Related]
40. [The significance of ovarian and testicular steroids in lipid metabolism and atherogenesis]. Marek J Vnitr Lek; 1992 Sep; 38(9):913-20. PubMed ID: 1481391 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]